SEC Form 4 · accession 0001104659-18-048808

Liquidia Technologies Inc · LQDA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Stephen M Bloch

Director

Period of report

Jul 30, 2018

Accepted (ET)

Aug 1, 2018 · 5:13 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001330436

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F7	Jul 30, 2018	C	87,837	—	A	90,536	I	See footnote
Common Stock^F2,F7	Jul 30, 2018	C	89,630	—	A	180,166	I	See footnote
Common Stock^F3,F7	Jul 30, 2018	C	31,471	—	A	211,637	I	See footnote
Common Stock^F4,F7	Jul 30, 2018	C	680,266	—	A	891,903	I	See footnote
Common Stock^F5,F7	Jul 30, 2018	C	944,127	—	A	1,836,030	I	See footnote
Common Stock^F7	Jul 30, 2018	P	727,273	$11.00	A	2,563,303	I	See footnote

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series A Preferred Stock^F1,F7	—	Jul 30, 2018	C	918,657	D	—	—	Common Stock	87,837	0	I
Series A-1 Preferred Stock^F2,F7	—	Jul 30, 2018	C	650,427	D	—	—	Common Stock	89,630	0	I
Series B Preferred Stock^F3,F7	—	Jul 30, 2018	C	222,529	D	—	—	Common Stock	31,471	0	I
Series C Preferred Stock^F4,F7	—	Jul 30, 2018	C	5,254,658	D	—	—	Common Stock	680,266	0	I
Series D Preferred Stock^F5,F7	—	Jul 30, 2018	C	15,887,155	D	—	—	Common Stock	944,127	0	I
Warrant to purchase Series D Preferred Stock^F6,F7	$0.01	Jul 30, 2018	J	578,498	D	Jan 9, 2017	Dec 31, 2026	Series D Preferred Stock	578,498	0	I
Warrant to purchase Common Stock^F6,F7	$0.01	Jul 30, 2018	J	34,378	A	Jan 9, 2017	Dec 31, 2026	Common Stock	34,378	34,378	I

Explanation of responses

F1The Series A preferred stock had no expiration date and automatically converted into the Issuer's common stock on a 0.0956-for-1 basis immediately prior to the closing of the Issuer's initial public offering.
F2The Series A-1 preferred stock had no expiration date and automatically converted into the Issuer's common stock on a 0.1378-for-1 basis immediately prior to the closing of the Issuer's initial public offering.
F3The Series B preferred stock had no expiration date and automatically converted into the Issuer's common stock on a 0.1414-for-1 basis immediately prior to the closing of the Issuer's initial public offering.
F4The Series C preferred stock had no expiration date and automatically converted into the Issuer's common stock on a 0.1295-for-1 basis immediately prior to the closing of the Issuer's initial public offering.
F5The Series D preferred stock had no expiration date and automatically converted into the Issuer's common stock on a 0.0594-for-1 basis immediately prior to the closing of the Issuer's initial public offering.
F6Immediately prior to the closing of the Issuer's initial public offering and without payment of further consideration, the Warrant to purchase Series D Preferred Stock automatically became exercisable to purchase the Issuer's common stock. The transaction is listed solely for the purpose of reporting the change of the title and amount of securities underlying the warrant.
F7The securities are held directly by Canaan VIII L.P. ("Canaan LP"). Canaan Partners VIII LLC ("Canaan LLC" and together with Canaan LP, the "Canaan Entities") is the sole general partner of Canaan LP. Investment and voting decisions with respect to the securities held by Canaan LP are made by the managers of Canaan LLC, collectively. Dr. Bloch disclaims beneficial ownership in the securities held by the Canaan Entities, except to the extent of his pecuniary interest, if any, in such securities by virtue of the limited liability company interests he owns in Canaan LLC.

Remarks

Exhibit 24 - Power of Attorney (incorporated by reference to Power of Attorney filed as Exhibit 24 to the Form 3 filed by the Reporting Person on July 25, 2018)